What is NDC 23155-603?

23155-603 is the product NDC for clindamycin palmitate hydrochloride, Clindamycin palmitate hydrochloride 75 mg/5mL granule, for solution, listed with the FDA by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., NDC labeler code 23155. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for clindamycin palmitate hydrochloride?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

clindamycin palmitate hydrochloride NDC 23155-603

NDC codes

FDA NDC Directory

Product NDC (as listed)23155-603Labeler and product segments. Claims need a package NDC.

Product NDC at billing width23155-0603Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
23155-603-51	2315506035123155060351	1 BOTTLE in 1 CARTON (23155-603-51) / 100 mL in 1 BOTTLEMarketed from May 11, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): clindamycin palmitate hydrochloride
Generic name (nonproprietary): clindamycin palmitate hydrochloride
Active ingredients: Clindamycin palmitate hydrochloride — 75 mg/5mL
Dosage form: Granule, For solution
Route: Oral
Labeler: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.NDC labeler code 23155
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207047
Marketing start: May 11, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 23155-603_6b2e0bbb-397e-49b2-aaea-3ec3896b8bebSPL ID 6b2e0bbb-397e-49b2-aaea-3ec3896b8bebSPL set ID a2279019-9341-4346-8746-fea262b27dd8RxCUI 562266UNII VN9A8JM7M7
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N423155060351 followed by a unit qualifier and the quantity

Package 23155-0603-51. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 16, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin palmitate hydrochloride for oral solution is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the BOXED WARNING , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives(e.g., erythromycin). Anaerobes:…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 23155-603

What is NDC 23155-603?: 23155-603 is the product NDC for clindamycin palmitate hydrochloride, Clindamycin palmitate hydrochloride 75 mg/5mL granule, for solution, listed with the FDA by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: clindamycin palmitate hydrochloride.
What is the active ingredient?: Clindamycin palmitate hydrochloride.
Who is the labeler?: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., NDC labeler code 23155. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for clindamycin palmitate hydrochloride?: 1 other product NDC are listed under this name. See all clindamycin palmitate hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other clindamycin palmitate hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Clindamycin Palmitate Hydrochloride	Clindamycin palmitate hydrochloride 75 mg/5mL	Granule, For solutionOral	Chartwell RX, LLC	62135-926	62135-0926-01